{
    "2018-10-29": [
        [
            {
                "time": "",
                "original_text": "白雲山：前三季度净利34.39亿元 同比增131%",
                "features": {
                    "keywords": [
                        "白雲山",
                        "前三季",
                        "净利",
                        "同比增",
                        "131%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "狂犬疫苗等大品种快速增长 白雲山前三季净利润同比大增132%",
                "features": {
                    "keywords": [
                        "狂犬疫苗",
                        "大品种",
                        "快速增长",
                        "白雲山",
                        "前三季",
                        "净利润",
                        "同比大增",
                        "132%"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "白雲山发布三季度财报 归母净利润同比大增132%",
                "features": {
                    "keywords": [
                        "白雲山",
                        "三季度",
                        "财报",
                        "归母净利润",
                        "同比大增",
                        "132%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}